FDA Advisory Panel Finds Hologic


The FDA is not required to accept, but traditionally follows the recommendations of its advisory panels. The panel recommended approval of the device contingent upon several conditions, including long-term follow up of current pivotal trial patients, a new post approval study of new patients and physicians, and more specific labeling recommendations.

Published on : Fri, 14 Dec 2007


Print as PDF
The FDA is not required to accept, but traditionally follows the recommendations of its advisory panels. The panel recommended approval of the device cont

No comment


Please login to leave a comment...

Highlighted Products